Unique ID issued by UMIN | UMIN000031585 |
---|---|
Receipt number | R000036055 |
Scientific Title | The effects of food intake on insulin resistance and obesity |
Date of disclosure of the study information | 2018/03/20 |
Last modified on | 2018/03/05 14:23:17 |
The effects of food intake on insulin resistance and obesity
The effects of Onsen alga powder intake on insulin resistance and obesity
The effects of food intake on insulin resistance and obesity
The effects of Onsen alga powder intake on insulin resistance and obesity
Japan |
Not applicable
Adult |
Others
NO
A placebo controlled double blind clinical trial to evaluate of the effects of Onsen alga on insulin resistance and obesity
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Not applicable
Measurement of waist circumference, measurements of height and weight, measurement of vital sign, blood examination, findings and evaluations of a doctor, and a health state diary
From the baseline to Week 12
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Treatment
Food |
Taking in 5 capsules of test sample after breakfast or in the morning every day for 12 weeks
Taking in 5 capsules of placebo sample after breakfast or in the morning every day for 12 weeks
20 | years-old | <= |
64 | years-old | >= |
Male and Female
1) Age: from 20 to 64 years old
2) BMI: 25 or more but less than 30
1) Those who have more than 2.5 times of reference value of gamma-GT (gamma-GTP)
2) Those who have more than 2.5 times of reference value of AST (GOT)
3) Those who have more than 2.5 times of reference value of ALT (GPT)
4) Those who have more than 6.5 % of HbA1c value
5) Those who are taking a medicine that may influence test results. e.g. medicine that decreases the blood sugar level, etc.
6) Those who have been on a daily basis taken a health food(s) that may influence test results. e.g. health food that may decrease the blood sugar level, etc.
7) Women who are in pregnancy or may become pregnant, or are nursing
8) Those who are "Alcoholism"
9) Those who may have an allergy to the ingredient of the test sample
10) Participants in other clinical trial
11) Those who have a medical history of severe hepatic disorders, renal disorders, or cardiovascular disease
12) Those who have hepatitis or its previous history
13) Those who have severe anemia
14) Those who have hypertension
15) Those who have hyperlipidemia
16) Those who were judged inappropriate to join the study by doctor in charge
30
1st name | |
Middle name | |
Last name | Takashi Koikeda |
Shiba Palace Clinic
Chair
6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan
+81-3-5408-1590
jimukyoku@mail.souken-r.com
1st name | |
Middle name | |
Last name | Ko Masuda |
SOUKEN Co., Ltd
Management Division
3F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan
+81-3-5408-1555
k_masuda@mail.souken-r.com
SOUKEN Co., Ltd.
METI(Japan)
Japanese Governmental office
Saravio Cosmetics Ltd.
NO
芝パレスクリニック (東京都) Shiba Palace Clinic (Tokyo)
株式会社SOUKEN SOUKEN Co. Ltd.
2018 | Year | 03 | Month | 20 | Day |
Unpublished
Completed
2017 | Year | 08 | Month | 24 | Day |
2017 | Year | 10 | Month | 18 | Day |
2018 | Year | 01 | Month | 10 | Day |
2018 | Year | 02 | Month | 02 | Day |
2018 | Year | 02 | Month | 08 | Day |
2018 | Year | 02 | Month | 23 | Day |
2018 | Year | 03 | Month | 05 | Day |
2018 | Year | 03 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036055